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ABSTRACT

The present invention provides a new process for the preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride,
wherein this compound is prepared directly from the chloromethylalcohol. Importantly, the process of the present
invention results in higher yields of 2S,3S-N-isobutyl-N-(2hydroxy -3 -amino -4-phenylbu tyl) -pnitrobenzenesulfonylamide hydrochloride without sacrificing its purity. The processes of the present invention can be
used to prepare not only the 2S,3S-derivative, but also the
2R,3S-, 2S,2R- and the 2R,3R-derivatives.
27 Claims, 1 Drawing Sheet
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PREPARATION OF 2S,3S-N-ISOBUTYL-N-(2HYDROXY-3-AMINO-4-PHENYLBUTYL)-PNITROBENZENESULFONYLAMIDE
HYDROCHLORIDE AND OTHER
DERIVATIVES OF 2-HYDROXY-l,3DIAMINES

Unfortunately, this process has a number of drawbacks.
Some of the drawbacks associated with this process include
high reaction temperatures which lead to the formation of
side products; low solubility of intermediates in the reaction
solvent which requires high processing temperatures during
work-up which, in turn, leads to longer cycle times, material
handling losses, etc.; and the like. As such, there remains a
need in the art for an improved process for preparing
2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-pnitrobenzenesulfonylamide hydrochloride which overcomes
the drawbacks associated with the currently used process.
Quite surprisingly, the present invention fulfills this and
other needs.

5

CROSS-REFERENCE TO RELATED

APPLICATION
This patent application claims the benefit of U.S. Provisional Patent Application No. 60/172,043, filed Dec. 23,
1999, which is incorporated herein by reference in its
entirety for all purposes.
BACKGROUND OF THE INVENTION
Human immunodeficiency virus (HIV), the causative
agent of acquired immunodeficiency syndrome (AIDS),
encodes three enzymes, including the well-characterized
proteinase belonging to the aspartic proteinase family, the
HIV protease. Inhibition of this enzyme has been regarded
as a promising approach for treating AIDS. Hydroxyethylamine isosteres have been extensively utilized in the synthesis of potent and selective HIV protease inhibitors.
However, this modern generation of HIV protease inhibitors
has created an interesting challenge for the synthetic organic
chemist. Advanced x-ray structural analysis has allowed for
the design of molecules that fit closely into active sites on
enzymes creating very effective drug molecules.
Unfortunately, these molecules, designed by molecular
shape, are often difficult to produce using conventional
chemistry.
The modern generation of HIV inhibitors has structural
similarities in a central three-carbon piece containing two
chiral carbons that link two larger groups on each side (see,
e.g., Parkes, et aI, J. Org. Chern., 39:3656 (1994)). In
general, the chemical bond from the central part to one of the
larger groups is a carbon-nitrogen bond which is usually
accomplished by reacting an epoxide with an amine. 2S,3SN -isobuty 1- N -(2- hydroxy-3-amino-4-phenylbutyl)-pnitrobenzenesulfonylamide hydrochloride is a key intermediate in the synthesis of protease inhibitors (see, e.g., U.S.
Pat. Nos. 5,585,397, 5,723,490 and 5,783,701 as well as
PCT International Publication No. WO 94/0563, the teachings of all of which are incorporated herein by reference).
The process currently used to prepare 2S,3S-N-isobutyl-N(2 - hydro xy - 3 - am ino - 4 -p he n yl bu t yl) -pnitrobenzenesulfonylamide hydrochloride is illustrated in
FIG. I.
As illustrated in FIG. I, 2S,3S-N-isobutyl-N-(2-hydroxy3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide
hydrochloride is prepared by a 4-step process starting from
a commercially available (Aerojet Fine Chemicals
(Sacramento, Calif.)) starting material, 2S,3Schloromethylalcohol (2S,3S-CMA). In the first step, 2S,3SCMA is reacted with sodium hydroxide in THF/ethanol to
give the corresponding epoxide in 91 % yield. In the second
step, the epoxide is dissolved in toluene and reacted with
excess isobutylamine at a temperature of about 75° C. to
about 80° C. to give Compound I. Reaction of Compound I
with p-nitrobenzenesulfonyl chloride (i.e., nosyl chloride) in
toluene at a temperature of about 85° C. to about 90° c.,
followed by deprotecting of the Boc protecting group with
aqueous HCl at a temperature of about 85° C. to about 90°
C. gives Compound III, i.e., 2S,3S-N-isobutyl-N-(2hydroxy-3 - amino -4-phenylbu tyl) -pnitrobenzenesulfonylamide hydrochloride, in 64% overall
yield.
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SUMMARY OF THE INVENTION
The present invention provides a new process for the
preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride,
i.e., Compound III. In this new process, one of the chemical
steps (i.e., the epoxide step) as well as material handling
losses associated with the previously used process have been
eliminated. More particularly, using the process of the
present invention, the halomethylalcohol, i.e., HMA, (e.g.,
chloromethylalcohol) is successfully converted to Compound III directly without the need to isolate the Bocepoxide. Numerous publications have described the synthesis of Compound I-like materials, but they all involve
reaction of an epoxide with an amine. As such, the process
of the present invention is the first example of a process
wherein a protease inhibitor intermediate is prepared
directly from the halomethylalcohol. Moreover, the process
of the present invention results in a higher yield of Compound III, while not sacrificing its purity. In addition, the
process of the present invention allows for the use of the
lower purity HMA, thereby eliminating a purification step.
Finally, it is pointed out that elimination of the epoxide step
eliminates the need to isolate a toxic intermediate (i.e., a
mutagen) and, thus, circumvents safety issues involved with
dust explosivity of the Boc-epoxide.
Other features, objects and advantages of the invention
and its preferred embodiments will become apparent from
the detailed description which follows.
BRIEF DESCRIPTION OF THE DRAWINGS
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FIG. 1 illustrates the process previously used to prepare
2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-pnitrobenzenesulfonylamide hydrochloride.
DESCRIPTION OF THE INVENTION AND
PREFERRED EMBODIMENTS
It has now been discovered that a protease inhibitor
intermediate, i.e., 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino4 -p he n yl bu t yl) -p - ni tro b e nze ne s ulfo n yl amide
hydrochloride, can be prepared directly from a halomethylalcohol (HMA) (e.g., chloromethylalcohol) without having
to isolate the Boc-epoxide. As such, the present invention
provides a new process for the preparation of 2S,3S-Niso buty 1- N -(2- hydroxy-3 -amino -4-pheny lbu ty 1) -pnitrobenzenesulfonylamide hydrochloride, i.e., Compound
III, wherein this compound is prepared directly from a
HMA. Importantly, the process of the present invention
results in higher yields of Compound III, while not sacrificing its purity. Moreover, the process of the present invention can be used to prepare not only the 2S,3S-derivative, but
also the 2R,3S-, 2S,2R- and the 2R,3R-derivatives.
As such, the first step in the process for preparing a
Compound of Formula III involves the preparation of a
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compound having the following general formula:

5

t-BocHN

NH

OH
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Y

the process compnsmg: combining a halomethylalcohol,
In the above process, a HMA is reacted with an amine at
e.g., chloromethylalcohol, with an amine, e.g., isobutya temperature ranging from about 50° C. to 100° C. to give
lamine (lEA), to form a reaction mixture, and heating the 15 the compound of Formula I in high yields. In a presently
reaction mixture until the reaction is complete, thereby
preferred embodiment, the HMA is reacted with an amine at
a temperature ranging from about 60° C. to about 75° C. to
forming the compound of Formula I, wherein the HMA has
give the Compound of Formula I in very high yields (about
the following general formula:
98-99% yield). The amine used in the above process can be
20 a primary amine, a secondary amine, a substituted amine
(e.g., N-substituted sulfonamides, etc.), hydrazines and substituted hydrazines (e.g., N-substituted hydrazine, etc.).
Exemplar amines include, but are not limited to,
methylamine, ethylamine, isopropylamine, n-butylamine,
25 isobutylamine, cyclohexylamine, benzylamine, paraOH
nitrobenzylamine, dimethylamine, isobutylmethylamine,
decahyroquinoline, decahydroisoquinoline, pyrimidine,
iso bu t yIp ar ani tro be nze ne s ulfo n amide,
me th yIp ar ani tro b e nze ne s ulfo n am ide,
In the above process, X is a leaving group (e.g., a halo
30 isobutylmetanitrobenzenesulfonamide, hydrazine, substigroup, such as chloro, bromo, fiuoro or iodo, a tosylate
tuted hydrazines, etc.
group, a mesylate group, etc.); R 1 is an amino acid side chain
In a presently preferred embodiment, the amine employed
or a functionalized amino acid side chain (e.g., an alkyl
in the above process is isobutylamine (lEA). Importantly,
group, a benzyl group, a phenyl thiomethyl group, a prothe solvent employed in the previously used method (i.e.,
toluene) has been eliminated and, in this embodiment, the
tected hydroxymethyl group, an S-alkyl group, a nitroben2
35
reaction
is conducted in neat IBA, using IBA as the reaction
zenyl group, etc.); R is a protecting group (e.g., t-Boc
solvent. This simplifies the lEA recovery process (no frac(tert-butyloxycarboxy), i-Boc (iso-butyloxycarboxy), Cbz
tional distillation/column needed to separate lEA from
(benzyloxycarboxy), MOC (methoxycarboxy), Fmoc
toluene), and allows for the reaction to be carried out at
3
4
(fiuorenylmethoxycarbonyl), dibenzyl, etc.); and R and R
slightly lower temperatures. It has been found, however, that
are independently selected and are functional groups 40 under theses conditions, the reaction times can be relatively
long (-30 h). To reduce reaction times, it has been discovincluding, but not limited to, hydrogen, alkyl, cycloalkyl,
ered that an acid scavenger can be added to the reaction
aryl and -NHP, wherein P is selected from the group
mixture.
consisting of H, alkyl, cycloalkyl, aryl and a protecting
3
4
As such, in one embodiment of the above process, an acid
group or, alternatively, R and R together can form a cyclic
45 scavenger is added to the reaction mixture to reduce reaction
structure including, but not limited to, quinoline and
times. In a preferred embodiment, the acid scavenger has the
isoquinoline, etc.
general formula: M+B-, wherein M+ is selected from the
group consisting of K+, Na+, Li+, Ca+ 2 , Mg+ 2 and Al+ 3 ; and
B- is selected from the group consisting of -OH, HC0 3 - and
In a preferred embodiment, the HMA is a 2S,3Shalomethylalcohol (2S,3S-HMA). In a presently preferred 50 C0 3 -2, In a preferred embodiment, the acid scavenger is
sodium bicarbonate. In another preferred embodiment, the
embodiment, the 2S,3S-HMA has the following formula:
acid scavenger is potassium bicarbonate. When an acid
scavenger is added to the reaction mixture, about 0.5 to 2
equivalents are added. In a presently preferred embodiment,
55 about 1 equivalent of the acid scavenger is added to the
reaction mixture. It has been found that by adding even only
1.05 equivalents of an acid scavenger (e.g., sodium
bicarbonate) to the reaction mixture, the reaction times can
be reduced from 30 hours to less than 4 hours. Moreover,
t-BocHN
60 this reduction in reaction times can be achieved without
OH
sacrificing product quality and/or yield. It will be readily
apparent to those of skill in the art that other acid scavengers,
base phosphates, etc. can be used in the methods of the
present invention to reduce reaction times.
In another preferred embodiment, the Compound of For- 65
Thus, as illustrated in Table I, the reaction rates of the base
mula I has the following formula:
catalyzed reaction of chloromethylalcohol (CMA) with
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isobutylamine are comparable to those of the epoxide with
isobutylamine, with the reaction being substantially complete in 3 hours.
5

TABLE I
Rxn Time (h)

% Compound I

o

0.15
90.8
97.7
98.6
98.8

1
2
3
4

10

Moreover, it is pointed out that the Boc-epoxide
employed in the previously used method is thermally
unstable, and at higher temperatures (>70° C.) will undergo
a deprotecting reaction to give free amine which, in turn,
leads to a variety of side-reactions. In contrast, HMA, e.g.,
CMA, is more thermally stable than Boc-epoxide. The
higher thermal stability of HMA, e.g., CMA, coupled with
lower reaction/processing temperatures allows for Compound III to be prepared in a much higher yield and purity.
Moreover, using the above process, the purity of isolated
Compound I is in the neighborhood of 98.7 to 98.8% (area
%) by HPLC. Typical results for the reaction of 2S,3S-CMA
with isobutylamine to give Compound I are illustrated
below:

15

20

and, (c) adding the first reaction mixture with the second
reaction mixture to form a third reaction mixture, and
heating the third reaction mixture until the reaction is
complete, thereby forming the compound of Formula II.
In the above process, R 1 is an amino acid side chain or a
functionalized amino acid side chain; R 2 is a protecting
group; and R3 and R 4 are independently selected and are
functional groups including, but not limited to, hydrogen,
alkyl, cycloalkyl, aryl and -NHP, wherein P is selected
from the group consisting of H, alkyl, cycloalkyl, aryl and
a protecting group or, alternatively, R3 and R 4 together can
form a cyclic structure including, but not limited to, quinoline and isoquinoline. In a presently preferred embodiment,
the compound of Formula I has the following general
formula:

25

30

t-BocHN

TABLE II
OH
Reaction #
CP086-135
CP086-143
CP086-147
CP086-160

(HP)
(HP)
(HP)
(HP)

Scale*

Yield

Purity

g
g
g
g

98.5%
98.5%
NO
99%

98.8%
98.7%
98.8%
98.8%

100
100
100
250
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In another preferred embodiment, the Compound of Formula II has the following general formula:

In one embodiment, the above process further comprises
recovering (e.g., isolating and purifying) the Compound of
Formula I from the reaction mixture. However, in a presently preferred embodiment, the Compound of Formula I is
filtered and used in the next step without first being purified.

40

45

t-BocHN

The second step in the process for preparing a Compound
of Formula III involves the preparation of a compound
having the following general formula:
50
II

In the first step of the above process, nosyl chloride is
combined with an alkyl acetate to form a first reaction
mixture. Alkyl acetates suitable for use include, but are not
limited to, methyl acetate, ethyl acetate, isopropyl acetate,
55 isobutyl acetate, etc. In a presently preferred embodiment,
ethyl acetate is employed. In the second step of the above
process, a tertiary amine is combined with a Compound of
Formula I in an aromatic solvent to form a second reaction
mixture. Exemplar tertiary amines include, but are not
60 limited to, triethylamine, diisopropylethylamine, pyridine
the process compflsIng:
(a) combining
and N-methylmorpholine. In a presently preferred
p-nitrobenzenesulfonyl chloride, i.e., nosyl chloride, with an
embodiment, triethylamine is used. Suitable aromatic
alkyl acetate to form a first reaction mixture; (b) combining
solvents, include, but are not limited to, toluene, benzene
a tertiary amine (e.g. triethylamine (TEA)) with a compound
and xylene. In a presently preferred embodiment, toluene is
of Formula I in an aromatic solvent (e.g., toluene) to form 65 used. In the third step of the above process, the first reaction
a second reaction mixture, the compound of Formula I
mixture is added to the second reaction mixture to form a
having the following general formula:
third reaction mixture, and the third reaction mixture is

US 6,852,887 B2
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heated until the reaction is complete. In a presently preferred
embodiment, the first reaction mixture is heated or warmed
prior to adding it to the second reaction mixture. The third
reaction mixture is heated to a temperature ranging from
about 50° C. to about 100° C. and, more preferably, to a 5
temperature ranging from about 60° C. to about 75° C.
Ethyl acetate is a good solvent for Compound I and
t-BocHN
Compound II intermediates; however, under certain
conditions, Compound I will react with ethyl acetate to give
OH
N-acetyl Compound I. As such, it has now been surprisingly 10
discovered that the best way to carry out the above process,
In the above process, the HMA is reacted with a sulfonai.e., the second step in the preparation of the Compound of
mide. Suitable sulfonamides include those having the folFormula III, is to dissolve the nosyl chloride in ethyl acetate
lowing general formula:
(nosyl chloride is not very soluble in toluene), and then add
it to a solution of the Compound of Formula I in toluene that 15
has been warmed to a temperature of about 70° C. Under
these conditions, the reaction is instantaneous and is complete when the addition is done. Moreover, since nosyl
chloride is much more reactive than ethyl acetate, formation
of the N-acetyl Compound I is not detected. Further, addi- 20
tion of ethyl acetate to the reaction mixture improves the
wherein: R 5 and R 6 are independently selected and are
solubility of Compound II in the reaction mixture, thereby
functional groups including, but not limited to, alkyl,
allowing the processing to be conducted at about 70° C.
instead of at about 85° C. Use of ethyl acetate as a co-solvent
cycloalkyl and aryl. In a preferred embodiment, R 5 is alkyl
also improves the partitioning of the Compound of Formula 25 and R 6 is aryl. In a further preferred embodiment, the aryl
II into the organic phase and, thus, minimizes loss due to
has the general formula:
product loss in aqueous phase. Further, use of lower reaction
temperature (70° C. versus 85-90° C.) also improves the
quality of the Compound of Formula II since side reactions,
such as de-protecting, etc., are minimized at lower tempera- 30
tures.
In an alternative embodiment, the Compound of Formula
II can be prepared directly from a HMA. As such, the present
z
invention provides a process for the preparation of a compound having the general formula:
35
wherein: Z is a functional group including, but not limited
II
to, hydrogen, alkyl, halogen, hydroxy, alkoxy, -N0 2 and
-NAP, wherein P is a protecting group. In a preferred
embodiment, the sulfonamide is selected from the group
40 consisting of isobutylparanitrobenzenesulfonamide, isobutylmetanitrobenzenesulfonamide and isobutylorthonitrobenzenesulfonamide.
In one embodiment of the above process, an acid scavthe process compnsmg: combining a halomethyl alcohol 45 enger can be added to the reaction mixture to reduce reaction
(HMA) with a sulfonamide to form a reaction mixture, and
times. In a preferred embodiment, the acid scavenger has the
heating said reaction mixture until the reaction is complete,
general formula: M+B-, wherein M+ is selected from the
thereby forming the compound of Formula II, wherein said
group consisting of K+, Na+, Li+, Ca+ 2 , Mg+ 2 and Al+ 3 ; and
HMA has the following general formula:
B- is selected from the group consisting of -OH, HC0 3 - and
50 C0 3 -2, In a preferred embodiment, the acid scavenger is
sodium bicarbonate. In another preferred embodiment, the
acid scavenger is potassium bicarbonate. When an acid
scavenger is added to the reaction mixture, about 0.5 to 2
equivalents are added. In a presently preferred embodiment,
55 about 1 equivalent of the acid scavenger is added to the
reaction mixture. In this process, a HMA is reacted with a
In the above process, R 1 is an amino acid side chain or a
sulfonamide at a temperature ranging from about 50° C. to
2
functionalized amino acid side chain; R is a protecting
125° C. to give the compound of Formula II in high yields.
group; R 3 is a functional group including, but not limited to,
In a presently preferred embodiment, the HMA is reacted
hydrogen, alkyl, cycloalkyl, aryl and -NHP, wherein P is
selected from the group consisting of H, alkyl, cycloalkyl, 60 with a sulfonamide at a temperature ranging from about 60°
C. to about 80° C. to give the Compound of Formula II in
aryl and a protecting group; R 4 is a functional group
very
high yields.
including, but not limited to, alkyl, cycloalkyl and aryl; and
The final step in the process of the present invention
X is a leaving group.
In a preferred embodiment, the HMA is a 2S,3S- 65 involves the conversion of a Compound of Formula II to a
Compound of Formula III, the Compound of Formula III
halomethyl-alcohol (2S,3-HMA). In a presently preferred
embodiment, the 2S,3S-HMA has the following formula:
having the following general formula:

6
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in which R 1 is an amino acid side chain or a functionalized
amino acid side chain; R 3 is a functional group including,
but not limited to hydrogen, alkyl, cycloalkyl, aryl and
-NHP, wherein P is selected from the group consisting of
H, alkyl, cycloalkyl, aryl and a protecting group; and X- is
the conjugate base of an acid having a pKa of less than about
4. The process for converting a Compound of Formula II to
a Compound of Formula III comprises: (a) combining a
Compound of Formula II with an aromatic solvent/alkyl
acetate (e.g., toluene/ethyl acetate) to form a reaction
mixture, and heating the reaction mixture, the Compound of
Formula II having the following general formula:

10

15

20

II 25

30

and, (b) treating the reaction mixture with an acid having a
pKa ofless than about 4 (e.g., hydrochloric acid (HCI)) until
the reaction is complete, thereby forming the Compound of
Formula III. In a presently preferred embodiment, this
process further comprises recovering the Compound of
Formula III from the reaction mixture by cooling to 5° C.
and filtering.

35

40

In the above process, R 1 is an amino acid side chain or a
functionalized amino acid side chain; R 2 is a protecting
group; and R 3 is a member selected from the group con45
sisting of hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H, alkyl,
cycloalkyl, aryl and a protecting group; and X- is the
conjugate base of said acid.
In a presently preferred embodiment the Compound of
Formula II has the following formula:

50

55

t-BocHN
60

65

In another preferred embodiment, the Compound of Formula III has the following general formula:

In step (b) of the above process, the reaction mixture is
treated or contacted with an acid having a pKa of less than
about 4. Suitable acids include, but are not limited to, HCI,
HEr, CF 3 C0 2 H, CF 3 S0 3 H, CH 3 S0 3 H, H 2 S0 4 , citric acid,
tartaric acid, oxalic acid and p-toluene sulfonic acid. The
reaction mixture is treated with the acid for a time period of
at lease about 0.5 hours and, typically, for a period of time
ranging from about 1 to about 5 hours. In a presently
preferred embodiment, the acid is aqueous hydrochloric acid
(HCI). In this embodiment, the hydrochloric acid can be, for
example, about 37% aqueous hydrochloric acid. In another
preferred embodiment, the hydrochloric acid is gaseous
hydrochloric acid. In this embodiment, the gaseous hydrochloric acid can be bubbled through the reaction mixture. In
another presently preferred embodiment, the acid is methanesulfonic acid (CH 3 S0 3 H). In a presently preferred
embodiment, the Compound of Formula III is recovered
from the reaction mixture.
In addition to the foregoing, it has also been discovered
that a halogenated solvent (e.g., methylene chloride) is a
superior solvent than toluene or toluene/ethyl acetate for
synthesizing the Compounds of Formulae II and III. The
higher solubility of Compound I-III intermediates in a
halogenated solvent (e.g., methylene chloride) allows for the
reactions to be carried out at much lower temperatures
(about 30 to 35° C. lower than the toluene/ethyl acetate
process and about 45-50° C. lower than the toluene
process). The ability to conduct the reactions at lower
temperatures has a profound effect on the quality and yield
of the resulting material. Low reaction temperatures minimize decomposition and other side-reactions (e.g.,
deprotecting), thereby leading to products with fewer impurities which, in turn, leads to improved quality and higher
yield (15 to 20% higher yield). It has been found that the rate
of the deprotecting reaction with, for example, aqueous HCI
is much slower in a halogenated solvent (e.g., methylene
chloride) than in toluene or toluene/ethyl acetate. For
example, in toluene/ethyl acetate the time required to
achieve >99% conversion is about 3 hours, whereas in
methylene chloride, it is nearly 5 days. However, it has
surprisingly been discovered that the use of, for example,
gaseous HCI, instead of aqueous HCI, will reduce the
reaction time from 5 days to 3 hours. An additional advantage for using gaseous HCI is that it does not require
additional stripping to remove the water. When HCI is
employed as the acid, the final product (Compound III) is a
hydrochloride salt, and it is important to remove water in
order to achieve a good yield. However, this problem is
eliminated when anhydrous gaseous HCI is used. Moreover,
the product quality of crude Compound III prepared by the
halogenated solvent route is much better than that of crude
Compound III prepared by the toluene or toluene/ethyl
acetate processes. Consequently, the yield of the isolated
Compound III is nearly 15% higher with the halogenated
solvent process. In addition, the intermediates do not have to
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be isolated when a halogenated solvent (e.g., methylene
chloride) is used. It is noted that, e.g. the sulfonamide
impurity is soluble in methylene chloride; otherwise, it is
very difficult to remove.
As such, in one embodiment, the present invention provides a process for preparing a compound having the following general formula:

5

t-BocHN

II 10

15

the process comprising: (a) combining nosyl chloride with a
halogenated solvent (e.g., methylene chloride) to form a first
reaction mixture; (b) combining a tertiary amine (e.g.,
triethylamine) with a compound of Formula I in a halogenated solvent (e.g., methylene chloride) to form a second
reaction mixture, the compound of Formula I having the
following general formula:

20

In the above process, a halogenated solvent is employed.
Suitable halogenated solvents include, but are not limited to,
methylene chloride, chloroform, trifiuorotoluene (oxsol),
parachlorotrifiuorotoluene and trichloroethylene. In a preferred embodiment, the halogenated solvent is methylene
chloride. Suitable tertiary amines include, but are not limited
to, triethylamine, diisopropylethylamine, pyridine and
N-methylmorpholine. In a preferred embodiment, the tertiary amine is triethylamine.
In another embodiment, the present invention provides a
process for preparing a compound having the following
general formula:

25
III

30

the process compnsmg: (a) combining a compound of
and, (c) adding the first reaction mixture to the second
35 Formula II with a halogenated solvent (e.g., methylene
reaction mixture to form a third reaction mixture, and
chloride) to form a reaction mixture and heating the reaction
heating the third reaction mixture to a temperature ranging
mixture to a temperature ranging from about 10° C. to about
from about 10° C. to about 50° C. and, more preferably, to
50° C. and, more preferably, to a temperature ranging from
a temperature ranging from about 30° C. to about 35° C.
about 30° C. to about 35° c., the compound of Formula II
until the reaction is complete, thereby forming the com- 40 having the following general formula:
pound of Formula II. In a presently preferred embodiment,
the first reaction mixture is heated or warmed prior to adding
II
it to the second reaction mixture.
In the above process, R 1 is an amino acid side chain or a
45
functionalized amino acid side chain; R 2 is a protecting
3
group; and R is a functional group including, but not
limited to, hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H, alkyl,
cycloalkyl, aryl and a protecting group.
50
In a presently preferred embodiment, the Compound of
and, (b) treating the reaction mixture with an acid having a
pKa of less than about 4 (e.g., hydrochloric acid) until the
Formula I has the following formula:
reaction is complete, thereby forming the compound of
Formula III. Exemplar halogenated solvents includes, but
55 are not limited to, the following: methylene chloride,
chloroform, trifiuorotoluene (oxsol), parachlorotrifiuorotoluene and tricloroethylene. In a presently preferred
embodiment, the halogenated solvent is methylene chloride.
In the above process, R 1 is an amino acid side chain or a
t-BocHN
NH
2
60 functionalized amino acid side chain; R is a protecting
group; and R 3 is a member selected from the group conOH
sisting of hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H alkyl,
cycloalkyl, aryl and a protecting group; and X- is the
65 conjugate base of the acid employed in the reaction.
In another preferred embodiment, the Compound of ForIn a presently preferred embodiment, the Compound of
mula II has the following formula:
Formula II has the following formula:

Y
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OH
t-BocHN

(b) adding to the first reaction mixture nosyl chloride while
stirring the reaction mixture, and recovering the organic
10 layer of the reaction mixture to form a solution; and (c)
reacting the solution with an acid having a pKa of less than
about 4 until the reaction is complete, thereby forming the
compound
of Formula III.
In another preferred embodiment, the Compound of ForIn the above process, R 1 is an amino acid side chain or a
mula III has the following general formula:
15 functionalized amino acid side chain; R 2 is a protecting
group; R 3 is a functional group including, but not limited to,
hydrogen, alkyl, cycloalkyl, aryl and -NHP, wherein P is
selected from the group consisting of H, alkyl, cycloalkyl,
aryl and a protecting group; and L is a leaving group.
20
In a presently preferred embodiment, the HMA is a
2S,3S-HMA. In a presently preferred embodiment, the
2S,3S-HMA has the following formula:

25

In step (b) of the above process, the reaction mixture is
treated or contacted with an acid having a pKa of less than
about 4. Exemplar acids include, but are not limited to, HCI,
HBr, CF 3 C0 2 H, CF 3 S0 3 H, CH 3 S0 3 H, H 2 S0 4 , citric acid,
tartaric acid, oxalic acid and p-toluene sulfonic acid. The
reaction mixture is treated with the acid until the reaction is
complete and, typically, for a time period of at lease about
0.5 hours and, more preferably, for a period of time ranging
from about 1 to about 5 hours. In one preferred embodiment,
the hydrochloric acid is aqueous hydrochloric acid. In this
embodiment, the hydrochloric acid can be, for example,
about 37% aqueous hydrochloric acid. In another preferred
embodiment, the hydrochloric acid is gaseous hydrochloric
acid. In this embodiment, the gaseous hydrochloric acid can
be bubbled through the reaction mixture. In another preferred embodiment, the acid is methanesulfonic acid
(CH 3 S0 3 H). In a presently preferred embodiment, the Compound of Formula III is recovered from the reaction mixture.
In another embodiment, the present invention provides a
process for preparing a Compound of Formula III from a
HMA, the Compound of Formula III having the following
general formula:

30

t-BocHN

OH

35

In another presently preferred embodiment, the Compound
of Formula III has the following formula:

40

45

In the above process, an amine is combined with a
halogenated solvent. Suitable amines include, but are not
50 limited to, primary amines, secondary amines, substituted
amines, hydrazines and substituted hydrazines. Exemplar
III
amines include, but are not limited to, methylamine,
ethylamine, isopropylamine, n-butylamine, isobutylamine,
cyclohexylamine, benzylamine, paranitrobenzylamine,
55 dimethylamine, isobutylmethylamine, decahyroquinoline,
decahydroisoquinoline, pyrimidine, isobutylhydrazine and
t-Boc-hydrazine. In a preferred embodiment, the amine is a
primary amine. In a presently preferred embodiment, the
amine is isobutylamine (lEA), preferably neat lEA. In the
the process comprising: (a) combining a halomethyl alcohol 60 above process, a halogenated solvent is employed. Exemplar
(HMA) and an amine (e.g., isobutylamine (lEA)) in a
halogenated solvents includes, but are not limited to, the
halogenated solvent (e.g., methylene chloride) with an acid
following: methylene chloride, chloroform, trifiuorotoluene
scavenger to form a reaction mixture, and heating the
(oxsol), parachlorotrifiuorotoluene and trichloroethylene. In
reaction mixture to a temperature ranging from about 10° C.
a presently preferred embodiment, the halogenated solvent
to about 50° C. and, more preferably, to a temperature 65 is methylene chloride.
ranging from about 30° C. to about 35° c., wherein the
In step (c) of the above process, the solution from step (b)
HMA has the following general formula:
is treated or contacted with an acid having a pKa of less than
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about 4. Exemplar acids include, but are not limited to, HCI,
HBr, CF 3 C0 2 H, CF 3 S0 3 H, CH 3 S0 3 H, H 2 S0 4 , citric acid,
tartaric acid, oxalic acid and p-toluene sulfonic acid. The
solution is treated with the acid until the reaction is complete. Typically, the solution is treated for a time period of 5
at lease about 0.5 hours and, more preferably, for a time
period ranging from about 1 to about 5 hours. In one
preferred embodiment, the acid is hydrochloric acid. In
another preferred embodiment, the acid is methanesulfonic
10
acid (CH 3 S0 3 H).
In yet another embodiment, the present invention provides a process for preparing a Compound of Formula III
from a compound of Formula I, the Compound of Formula
III having the following general formula:
15
III

20

the process comprising: (a) adding a Compound of Formula
I in a halogenated solvent (e.g., methylene chloride) with a
tertiary amine and nosyl chloride to form a reaction mixture,
and heating the reaction mixture at a temperature ranging
from about 10° C. to about 50° C. and, more preferably, to
a temperature ranging from about 30° C. to about 35° c.; the
compound of Formula I having the following general formula:

25

30

35

40

and (b) reacting the reaction mixture with an acid having a
pKa of less than about 4 until the reaction is complete,
thereby forming the Compound of Formula III.
In the above process, R 1 is an amino acid side chain or a
functionalized amino acid side chain; R 2 is a protecting
group; and R 3 is a member selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl and -NHP,
wherein P is selected from the group consisting of H alkyl,
cycloalkyl, aryl and a protecting group; and X- is the
conjugate base of the acid used in step (b).
In a presently preferred embodiment, the Compound of
Formula I has the following formula:

45

50

55

t-BocHN

60

OH

65

In another preferred embodiment, the Compound of Formula III has the following formula:

In the above process, a tertiary amine is combined with a
halogenated solvent. Suitable tertiary amines include, but
are not limited to, triethylamine, diisopropylethylamine,
pyridine and N-methylmorpholine. In a presently preferred
embodiment, triethylamine is used. Exemplar halogenated
solvents includes, but are not limited to, the following:
methylene chloride, chloroform, trifiuorotoluene (oxsol),
parachlorotrifiuorotoluene and trichloroethylene. In a presently preferred embodiment, the halogenated solvent is
methylene chloride.
In step (b) of the above process, the reaction mixture is
reacted with an acid having a pKa of less than about 4.
Exemplar acids include, but are not limited to, HCI, HBr;
CF 3 C0 2 H, CF 3 S0 3 H, CH 3 S0 3 H, H 2 S0 4 , citric acid, tartaric acid, oxalic acid and p-toluene sulfonic acid. The
solution is treated with the acid until the reaction is complete. Typically, the solution is treated for a time period of
at least about 0.5 hours and, more preferably, for a time
period ranging from about 1 to about 5 hours. In one
preferred embodiment, the acid is hydrochloric acid. In
another preferred embodiment, the acid is methanesulfonic
acid (CH 3 S0 3 H).
In a presently preferred embodiment, the process further
comprises washing the reaction mixture; heating the reaction
mixture to a temperature ranging from about 40° C. to about
45° c.; and then azeotropically drying the reaction mixture
prior to step (b). In another preferred embodiment, the
Compound of Formula III is recovered from the reaction
mixture. In one such embodiment, the recovery step comprises: (i) cooling the reaction mixture to a temperature of
about _5° c.; (ii) filtering the reaction mixture to remove the
N-isobutyl-p-nitrobenzenesulfonamide impurities and provide the compound of Formula III; and (iii) washing the
compound of Formula III and then drying it in vacuo.
Using the above processes, 2S,3S-N-isobutyl-N-(2hydroxy -3 -amino -4-phenylbu tyl) -pnitrobenzenesulfonylamide hydrochloride can be prepared
directly from the chloromethylalcohol (CMA) without having to isolate the Boc-epoxide. The process of the present
invention is the first demonstration of a process wherein a
protease inhibitor intermediate is prepared directly from the
halomethylalcohol. Again, this is extremely helpful because
elimination of the epoxide eliminates the need to isolate a
toxic intermediate (i.e., a mutagen) and, thus, circumvents
safety issues involved with dust explosivity of the Bocepoxide. Importantly, the process of the present invention
results in higher yields of Compound III, while not sacrificing its purity.
Those of skill in the art will readily understand that the
term "alkyl," as used herein, refers to a branched or
unbranched, saturated or unsaturated, monovalent hydrocarbon radical having from 1-12 carbons and, preferably, from
1-6 carbons. When the alkyl group has from 1-6 carbon
atoms, it is referred to as a "lower alkyl." Suitable alkyl
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radicals include, for example, methyl, ethyl, n-propyl,
hood of 98.7 to 98.8%. The isolated product was characteri-propyl, 2-propenyl (or allyl), n-butyl, t-butyl, i-butyl (or
ized by 1H/13C NMR and by HPLC/TLC analysis.
2-methylpropyl), etc. As used herein, the term alkyl encomB. Preparation of Compound II
Solution of Compound I in toluene was warmed to 70° C.
passes "substituted alkyls." Substituted alkyl refers to alkyl
as just described including one or more functional groups 5 and treated with triethylamine (220 g, 2.18 mol). Then, a
solution of p-nitrobenzenesulfonyl chloride (195 g, 0.88
such as lower alkyl, aryl, aralkyl, acyl, halogen (i.e.,
alkylhalos, e.g., CF 3 ), hydroxy (e.g., hydroxymethyl),
mol) in ethyl acetate (1 I) was added over 3 h. The organic
mixture was then washed sequentially at 65-70° C. with
amino, alkylamino, acylamino, acyloxy, alkoxy (e.g.,
water (400 mL), 5% aqueous sodium hydrogen carbonate
methoxymethyl), mercapto and the like. These groups may
be attached to any carbon atom of the lower alkyl moiety. 10 (400 mL) and water (400 mL). The product is obtained as a
solution in toluene/ethyl acetate and is used directly in
The term "cycloalkyl," by itself or in combination with
synthesis of Compound III. The yields, as determined by
other terms, represents cyclic versions of "alkyl." Examples
evaporating the solvent and isolating crude Compound II,
of cycloalkyl include cyclopentyl, cyclohexyl,
were in the neighborhood of 97 to 98%.
1-cyclohexenyl, 3-cyclohexenyl, cycloheptyl, and the like.
C. Preparation of Compound III
The cycloalkyl group may be substituted or unsubstituted. 15
The solution of Compound II in toluene/ethyl acetate at
The term "alkoxy" is used herein to refer to the -OR
65° C.-70° C. was treated with 37% aqueous hydrochloric
group, where R is a lower alkyl, substituted lower alkyl, aryl,
acid (160 g, 1.64 mol) over a period of 2 h. The mixture was
substituted aryl, aralkyl or substituted aralkyl. Suitable
then distilled at 70° C. under reduced pressure (500-600
alkoxy radicals include, for example, methoxy, ethoxy,
mm-Hg) until the residual ethyl acetate content was less than
phenoxy, t-butoxy (e.g., methoxyethoxy, methoxymethoxy, 20
5 mol % in toluene (as determined by lH NMR analysis),
etc.), etc.
and the water content was less than 1% (as determined by
The term "aryl," as used herein, refers to an aromatic
Karl Fischer analysis). When distillation was complete, the
substituent which may be a single ring or multiple rings
toluene volume was adjusted to 15% solids and ethanol (360
which are fused together, linked covalently, or linked to a
mL, denatured with 5 wt % Methanol) was added. The
common group such as an ethylene or methylene moiety. 25
mixture was cooled to ambient temperature over 2 h, held at
The aromatic ring(s) may include phenyl, naphthyl,
ambient for 1 h, then cooled to _5° C. to _10° C. for 1 h. The
biphenyl, diphenylmethyl, 2,2-diphenyl-1-ethyl, and may
precipitated solid was isolated by filtration, washed with
contain a heteroatom, such as thienyl, pyridyl and quinoxtoluene and n-hexanes, and dried in vacuo at 80° C. to give
alyl. The aryl group may also be substituted with halogen
247 g (73%) of Compound III. The purity of Compound III
atoms, or other groups such as nitro, carboxyl, alkoxy, 30
as determined by HPLC was 99.2 wt % (99.8 area %).
phenoxy, and the like. Additionally, the aryl group may be
Compound III was also characterized by 1H/13C NMR
attached to other moieties at any position on the aryl radical
analysis.
which would otherwise be occupied by a hydrogen atom
II. Process B: Methylene Chloride Process
(such as 2-pyridyl, 3-pyridyl and 4-pyridyl).
A. One Pot Process
In view of the foregoing, it will be readily apparent to 35
A solution of 2S,3S-CMA (44 g, 0.146 mol), isobutythose of skill in the art that the foregoing processes can be
lamine (11 g, 0.150 mol) in 270 mL of methylene chloride
used to prepare not only the 2S,3S-derivative, but also the
was stirred with sodium hydrogen carbonate (33 g, 0.4 mol)
2R,3S-, 2S,2R- and the 2R,3R-derivatives. Again, the proin water (100 g) for 5 h. is heated at a gentle reflux (-30° C.)
cess of the present invention results in higher yields of these
for 6 h. Then nosyl chloride (35.4 g, 0.157 moles) and
derivatives, while not sacrificing their purity.
40
triethylamine (17.7 g, 0.175 moles) was added and the
The invention will be described in greater detail by way
mixture stirred for 6 h at 30-35° C. The organic layer was
of specific examples. The following examples are offered for
removed and the residue washed with water (100 mL).
illustrative purposes, and are not intended to limit the
Gaseous HCI was bubbled through the solution for 2-3
invention in any manner. Those of skill in the art will readily
hours until the reaction was complete as indicated by HPLC
recognize a variety of non-critical parameters which can be 45
analysis. The residual acid is removed with a stream of
changed or modified to yield essentially the same results.
nitrogen gas and the reaction mixture was cooled to _5° C.
EXAMPLES
for 1 h. The mixture was filtered to give 60 g (89%) of
I. Process A: Toluene/Ethyl Acetate Process:
Compound III with 99.7% purity by HPLC.
A. Preparation of Compound I
B. Process Starting with Compound I
A solution of triethylamine (17.7 g, 0.175 mol) and
A mixture of 2S,3S-CMA (251.8 g, 0.84 mol), isobuty- 50
lamine 737.8 g (10.1 mol) and sodium hydrogen carbonate
Compound I (49.0 g 1.46 mol) in methylene chloride (270
(77.6 g, 92 mol) in water (323.9 g) is heated at a gentle reflux
mL) was heated to 30-35° C. and nosyl chloride (35.4 g,
(-60° C.) for 5 h. Water (1000 g) is added and excess
0.157 mol) in methylene chloride was added over 3 h. The
solution is heated to 35° C. and washed sequentially with
isobutyl amine is removed by distillation under nitrogen at
an internal reaction temperature of 70° C. (The recovery is 55 water (65 mL), 5% sodium bicarbonate solution (60 mL) and
approximately 85% and the recovered IBAcan be recycled).
water (80 mL). The solution was heated reflux and water
removed azeotropically. When Karl Fischer analysis of the
Additional water (500 g) is added and the product is isolated
by filtration. The precipitated solid is washed with water and
solution indicated that less than 0.1 % of water remained, the
dissolved in toluene (1500 g). The solution is reduced in
solution was cooled to ambient. Hydrogen chloride gas was
volume by 1/3 by distillation at 70° C. under reduced pressure 60 passed through the solution for 3 h until HPLC analysis
indicated that the reaction was complete. The mixture was
(300 mm-Hg) to remove water and residual isobutylamine.
cooled to 0-5° C. and filtered to give a white solid. The solid
The solution of Compound I in toluene is used directly in
synthesis of Compound II. However, in order to obtain
was washed with hexanes (65 mL) and dried in vacuo to give
yield/purity data, Compound I is isolated by evaporation of
59.5 g (89%) of compound III that was 99.7% pure by HPLC
the solvent and the resulting solid is dried in oven to constant 65 analysis.
weight. The yields normally range in the neighborhood of
It is understood that the examples and embodiments
98.5 to 99% with purities (HPLC) ranging in the neighbordescribed herein are for illustrative purposes only and that
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various modifications or changes in light thereof will be
suggested to persons skilled in the art and are to be included
within the spirit and purview of this application and scope of
the appended claims. All publications, patents, and patent
applications cited herein are hereby incorporated by reference for all purposes.
What is claimed is:
1. A process for preparing a compound having the following general formula:

5

10

III

4. The process in accordance with claim 1, further comprising recovering said compound of Formula III from said
reaction mixture.
5. The process in accordance with claim 1, wherein said
acid is a member selected from the group consisting of HCl,
HEr, CF 3 C0 2 H, CF 3 S0 3 H, CH 3 S0 3 H, H 2 S0 4 , citric acid,
20 tartaric acid, oxalic acid and p-toluene sulfonic acid.
said process comprising:
6. The process in accordance with claim 5, wherein said
acid is HCI.
(a) combining a compound of Formula II with an aromatic
7. The process in accordance with claim 5, wherein said
solvent/alkyl acetate to form a reaction mixture and
heating said reaction mixture, said compound of For- 25 acid is CH 3 S0 3 H.
8. The process in accordance with claim 6, wherein said
mula II having the following general formula:
hydrochloric acid is about 37% aqueous hydrochloric acid.
II
9. The process in accordance with claim 5, wherein said
hydrochloric acid is gaseous hydrochloric acid.
30
10. The process in accordance with claim 1, wherein said
alkyl acetate is a member selected from the group consisting
of methyl acetate, ethyl acetate, isopropyl acetate and isobutyl acetate.
11. The process in accordance with claim 1, wherein said
35
aromatic solvent is a member selected from the group
consisting of toluene, benzene and xylene.
(b) treating said reaction mixture with an acid having a
12. The process in accordance with claim 1, wherein said
pKa of less than about 4 until the reaction is complete,
aromatic solvent/alkyl acetate is toluene/ethyl acetate.
thereby forming said compound of Formula III;
13. The process in accordance with claim 1, wherein said
40
wherein:
reaction mixture is heated to a temperature ranging from
R 1 is an amino acid side chain or a functionalized amino
about 50° C. to about 100° C.
acid side chain;
14. The process in accordance with claim 1, wherein said
reaction mixture is heated to a temperature ranging from
R2 is a protecting group;
R3 is a member selected from the group consisting of 45 about 50° C. to about 80° C.
15. The process in accordance with claim 1, wherein said
hydrogen, alkyl, cycloalkyl, aryl and -NHP, wherein
reaction
mixture is treated with said acid for a time period
P is selected from the group consisting of H, alkyl,
of at least about 0.5 hours.
cycloalkyl, aryl and a protecting group; and
16. A process for preparing a compound having the
50
x- is the conjugate base of said acid.
following general formula:
2. The process in accordance with claim 1, wherein said
compound of Formula II has the following general formula:
III
15

55

t-BocHN

60

said process comprising:

65

3. The process in accordance with claim 2, wherein said
compound of Formula III has the following general formula:

(a) combining a compound of Formula II with a halogenated solvent to form a reaction mixture and heating
said reaction mixture to a temperature ranging from
about 10° C. to about 50° c., said compound of
Formula II having the following general formula:
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and
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(b) treating said reaction mixture with an acid having a
pKa of less than about 4 until the reaction is complete,
thereby forming said compound of Formula III;
wherein:

19. The process in accordance with claim 16, further
comprising recovering said compound of Formula III from
R 1 is an amino acid side chain or a functionalized amino 15 said reaction mixture.
20. The process in accordance with claim 16, wherein said
acid side chain;
halogenated solvent is a member selected from the group
2
R is a protecting group;
consisting of methylene chloride, chloroform, trifiuorotoluR3 is a member selected from the group consisting of
ene (oxsol), parachlorotrifiuorotoluene and trichloroethylhydrogen, alkyl, cycloalkyl, aryl and -NHP, wherein 20 ene.
P is selected from the group consisting of H alkyl,
21. The process in accordance with claim 16, wherein said
cycloalkyl, aryl and a protecting group; and
halogenated solvent is methylene chloride.
22. The process in accordance with claim 16, wherein said
x- is the conjugate base of said acid.
acid is a member selected from the group consisting of HCI,
17. The process in accordance with claim 16, wherein said
compound of Formula II has the following general formula: 25 HEr, CF 3 C0 2 H, CF 3 S0 3 H, CH 3 S0 3 H, H 2 S0 4 , citric acid,
tartaric acid, oxalic acid and p-toluene sulfonic acid.
23. The process in accordance with claim 22, wherein said
acid is HCI.
24. The process in accordance with claim 22, wherein said
30 acid is CH 3 S0 3 H.
25. The process in accordance with claim 23, wherein said
hydrochloric acid is gaseous hydrochloric acid.
t-BocHN
26. The process in accordance with claim 16, wherein said
reaction mixture is treated with said acid for a time period
35 of at least about 0.5 hours.
27. The process in accordance with claim 16, wherein said
reaction mixture is heated to a temperature ranging from
about 30° C. to about 35° C.
18. The process in accordance with claim 17, wherein said
compound of Formula III has the following general formula:

* * * * *

